Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A topochemical approach to explain morphiceptin bioactivity

T Yamazaki1, S Ro, M Goodman

  • 1Department of Chemistry, University of California, San Diego, La Jolla 92093.

Journal of Medicinal Chemistry
|March 19, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.

Journal of virology·1999
Same author

Health-related quality-of-life assessment of patients with life-threatening ventricular arrhythmias.

Pacing and clinical electrophysiology : PACE·1999
Same author

Structural and compositional determinants of cortistatin activity.

Journal of neuroscience research·1999
Same author

Molecular evolution of the COX7A gene family in primates.

Molecular biology and evolution·1999
Same author

Sequences from the 5' flanking region of the epsilon-globin gene support the relationship of Callicebus with the pitheciins.

American journal of primatology·1999
Same author

Model for the fetal recruitment of simian gamma-globin genes based on findings from two New World monkeys Cebus apella and Callithrix jacchus (Platyrrhini, Primates).

The Journal of experimental zoology·1999
Same journal

Development of Indole-3-yl-methylene-thiobarbital Derivatives as Inhibitors of HDAC8 Enzyme Activity.

Journal of medicinal chemistry·2026
Same journal

Discovery of a Potent NAMPT-Targeting PROTAC for the Suppression of Triple-Negative Breast Cancer via Macrophage Reprogramming.

Journal of medicinal chemistry·2026
Same journal

3',4'-Isopropylidene-α-galactosylceramide Enables Multidose Th1 Adjuvanticity Despite Limited Serial Serum IFN-γ Responsiveness.

Journal of medicinal chemistry·2026
Same journal

A Bioorthogonally Cleavable <i>N</i>-Oxide Linker for Prodrug Design: Elucidating the Structure-Cyclization Kinetics Relationships for Controlled Drug Release.

Journal of medicinal chemistry·2026
Same journal

A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

Journal of medicinal chemistry·2026
Same journal

Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

Journal of medicinal chemistry·2026
See all related articles

A new model explains morphiceptin

Area of Science:

  • Medicinal Chemistry
  • Molecular Modeling
  • Pharmacology

Background:

  • Opioid receptor interactions are crucial for pain management.
  • Morphiceptin's bioactivity is linked to specific pharmacophore arrangements.
  • Understanding these arrangements can guide the development of new analgesics.

Purpose of the Study:

  • To develop a topochemical model explaining morphiceptin's bioactivity.
  • To identify key conformational requirements for opioid receptor recognition.
  • To guide the design of novel peptide and nonpeptide opioid ligands.

Main Methods:

  • Synthesized and analyzed 10 stereoisomeric morphiceptin analogs.
  • Utilized 1H-NMR measurements to determine accessible conformations.
  • Employed computer simulations to analyze rotatable bond configurations.

Related Experiment Videos

Main Results:

  • Identified a requirement for a cis amide bond between residues 1 and 2.
  • Determined that Tyr and Phe side chains need a trans conformation (chi 1 = 180 degrees).
  • Established specific distances between key pharmacophores (Tyr N, Tyr OH, Phe ring).

Conclusions:

  • The developed topochemical model accurately predicts morphiceptin bioactivity.
  • The model highlights critical conformational features for opioid receptor binding.
  • This research provides a framework for designing potent opioid ligands.